Dillen Hannelore, Van de Velde Axelle, Withofs Chloë, Wynants Laure, Verbakel Jan Y
Leuven Unit for Health Technology Assessment Research (LUHTAR), Department of Public Health and Primary Care, KU Leuven, 7 Kapucijnenvoer, Leuven 3000, Belgium.
Academic Centre for General Practice, Department of Public Health and Primary Care, KU Leuven, 7 Kapucijnenvoer, Leuven 3000, Belgium.
JAC Antimicrob Resist. 2025 Jul 29;7(4):dlaf135. doi: 10.1093/jacamr/dlaf135. eCollection 2025 Aug.
The aim of this study is to analyse trends in paediatric antibiotic use in Belgian ambulatory care across three COVID-19 pandemic-related periods.
We conducted a retrospective time series analysis using autoregressive integrated moving average modelling. The analysis is based on anonymized pharmacy dispensing data for antibiotics delivered to Belgian children aged 0-12 years, retrieved from Farmanet for the period from 2014 until 2023. The outcome measures were the number of packages, expenditures and DDDs. Outcomes were analysed for all antibiotics collectively and for subgroups based on patient characteristics, prescriber specialty, geographic region and antibiotic characteristics.
Antibiotic use among children in Belgian ambulatory care sharply declined during the COVID-19 pandemic (-42.7%), followed by a gradual return to pre-pandemic levels (+66.9%), which was primarily driven by prescriptions of antibiotics commonly used for respiratory tract infections. The initial reduction exceeded expected seasonal variations. The largest decreases during the pandemic and subsequent increases were observed among children aged 7-12 years, those with standard reimbursement, in prescriptions by general practitioners and in rural areas of Flanders and the Walloon region.
The COVID-19 pandemic significantly disrupted paediatric antibiotic prescribing patterns in Belgian ambulatory care. These findings highlight the importance of sustained antimicrobial stewardship efforts, not only in routine healthcare settings but also during periods of altered care delivery.
本研究旨在分析比利时门诊护理中三个与新冠疫情相关时期儿童抗生素使用的趋势。
我们使用自回归积分移动平均模型进行了回顾性时间序列分析。该分析基于从Farmanet获取的2014年至2023年期间提供给比利时0至12岁儿童的抗生素匿名药房配药数据。结果指标为包装数量、支出和限定日剂量(DDD)。对所有抗生素以及根据患者特征、开处方者专业、地理区域和抗生素特征划分的亚组的结果进行了分析。
在新冠疫情期间,比利时门诊护理中儿童的抗生素使用急剧下降(-42.7%),随后逐渐恢复到疫情前水平(+66.9%),这主要是由常用于呼吸道感染的抗生素处方推动的。最初的减少超过了预期的季节性变化。在7至12岁儿童、享受标准报销的儿童、全科医生开具的处方以及弗拉芒和瓦隆地区的农村地区,疫情期间下降幅度最大,随后增加幅度也最大。
新冠疫情严重扰乱了比利时门诊护理中儿童抗生素的处方模式。这些发现凸显了持续开展抗菌药物管理工作的重要性,不仅在常规医疗环境中,而且在护理服务发生变化的时期也是如此。